D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison
To the EditorAutologous hematopoietic stem cell transplantation (autoHCT) remains standard of care for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM). Quadruplet inductio...
Authors
- Muzaffar H. Qazilbash (ORCID: https://orcid.org/0000-0003-2876-2886)
- Mark R. Tanner (ORCID: https://orcid.org/0000-0002-6516-0166)
- Robert Zygmunt Orlowski (ORCID: https://orcid.org/0000-0002-5723-4129)
- Hans Chulhee Lee (ORCID: https://orcid.org/0000-0001-8545-3292)
- Asad A. Haider (ORCID: https://orcid.org/0009-0005-5210-3380)
- Krina K. Patel (ORCID: https://orcid.org/0000-0002-8894-027X)
- Qaiser Bashir (ORCID: https://orcid.org/0000-0002-4086-6453)
- Oren Pasvolsky (ORCID: https://orcid.org/0000-0001-9193-0059)
- Jeremy Ramdial
- Yago Nieto
- Curtis Marcoux
- Samer Srour
- Paul Lin
- Yosra Aljawai (ORCID: https://orcid.org/0000-0002-1649-7651)
- Mahmoud R. Gaballa
- Neeraj Saini
- Denái R. Milton
- Bilal Islam
- Richard E. Champlin
- Elizabeth J. Shpall
- Partow Kebriaei
- Sheeba K. Thomas
- Guilin Tang
Institutions
- Dalhousie University (CA)
- The University of Texas MD Anderson Cancer Center (US)
- Dow University of Health Sciences (PK)
Publication Details
- Journal
- Leukemia & lymphoma/Leukemia and lymphoma
- Published
- 2026-06-26
- DOI
- https://doi.org/10.1080/10428194.2026.2688555
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Dr. Miriam and Sheldon G. Adelson Medical Research Foundation